Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

iCAD, Inc. announced that the Company will Host First Quarter 2009 Financial Results Conference Call on Thursday, April 30, 2009 iCAD, Inc. , an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announced that the Company will release financial results for the first quarter ended March 31, 2009, following the close of the market on Wednesday, April 29, 2009.

Ken Ferry, President and Chief Executive Officer, and Darlene Deptula-Hicks, Executive Vice President and Chief Financial Officer, will host a conference call for investors beginning at 10:00 a.m. Eastern Time on Thursday, April 30, 2009 to discuss first quarter 2009 financial results and to answer questions.

Shareholders and other interested parties may participate in the conference call by dialing +1-800-884-5695 (domestic) or + 1-617-786-2960 (international) and entering passcode 58061238 a few minutes before 10:00 a.m. ET on Thursday, April 30, 2009. The call will also be broadcast live on the Internet at www.streetevents.com, www.fulldisclosure.com and www.icadmed.com.

A replay of the conference call will be accessible two hours after its completion through May 7, 2009 by dialing +1-888-286-8010 (domestic) or +1-617-801-6888 (international) and entering passcode 84812114 . The call will also be archived for 90 days at www.streetevents.com, www.fulldisclosure.com and www.icadmed.com.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR)), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Currently available in more than 2,200 healthcare centers worldwide, iCAD’s solutions aid in the early detection of the most prevalent cancers including breast, colon, prostate and in the future, lung cancer. For more information, call (877) iCADnow or visit www.icadmed.com.

Source: iCAD, Inc.